The anticancer effect of formononetin on human multiple myeloma U266 cells via inhibition of STAT3 pathway was abrogated with the use of antioxidants such as N-acetyl-L-cysteine (NAC) and glutathione (GSH), suggesting that formononetin induces apoptosis via ROS production. Here, STAT3 is linked to plasma cell myeloma.